News WPD Pharmaceuticals Inc.

Equities

WBIO

CA92941F1053

Market Closed - Canadian Securities Exchange Other stock markets 03:48:22 2024-07-12 pm EDT			5-day change	1st Jan Change
0.005 ^CAD	-50.00%		-50.00%	-88.89%

May. 29	WPD Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 08	WPD Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

WPD Pharmaceuticals : ANNOUNCES SETTLEMENT OF DEBT FOR COMMON SHARES	Jun. 07	PU
WPD Pharmaceuticals : REINSTATEMENT OF TRADING OF WPD'S COMMON SHARES AND ANNUAL GENERAL MEETING	May. 30	PU
WPD Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 28	CI
CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO)	May. 24	NE
Canadian Investment Regulatory Organization Trade Resumption - WBIO	May. 24	AQ
WPD Pharmaceuticals : Receives Full Revocation of Cease Trade Order	May. 16	PU
WPD Pharmaceuticals : Announces Filing of Annual Financial Statements and Provides Corporate Update	May. 10	PU
WPD Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	May. 07	CI
WPD Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Feb. 05	CI
WPD Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Feb. 02	CI
WPD Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	Jan. 30	CI
WPD Pharmaceuticals : Sp. z o. o., received the second tranche of the funds	Nov. 02	PU
WPD Pharmaceuticals : Sp. z o. o., received the first tranche of the funds	23-09-08	PU
WPD Pharmaceuticals : Polish Subsidiary Signs Investment Agreement with ACRX Investments Limited	23-09-01	PU
WPD Pharmaceuticals : Announces Closing of Convertible Debenture Private Placement	23-06-16	PU
WPD Pharmaceuticals Inc. announced that it has received CAD 0.3 million in funding	23-06-14	CI
WPD Pharmaceuticals Inc. Provides Update on Research Project Pipeline	23-05-01	CI
WPD Pharmaceuticals Inc. Announces Directorate Appointments	23-05-01	CI
WPD Pharmaceuticals Inc. announced that it expects to receive CAD 0.3 million in funding	23-04-30	CI
WPD Pharmaceuticals Inc. Announces First Adult Patient Dosed in Phase 1B/2 Clinical Trial of Berubicin in the Treatment of Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy	23-01-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News WPD Pharmaceuticals Inc.

Equities

WBIO

CA92941F1053

Summary

Filters